NASDAQ
Oruka Therapeutics, Inc. (ORKA)
♥ 397 Thanks from members
Oruka Therapeutics, Inc. (ORKA) demonstrates exceptionally bullish market sentiment driven by positive clinical trial data, a robust pipeline including lead products ORKA-001 and ORKA-002, strong institutional backing, and an expanding cash runway supporting future BLA filings.